Literature DB >> 1637076

Features of the dopaminergic neurotoxin MPTP.

I J Kopin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1637076     DOI： 10.1111/j.1749-6632.1992.tb24527.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  16 in total

1.  The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.

Authors:  N G Levitskaya; E A Sebentsova; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2004-05

2.  Exercise protects against MPTP-induced neurotoxicity in mice.

Authors:  Kimberly M Gerecke; Yun Jiao; Amar Pani; Vishwajeeth Pagala; Richard J Smeyne
Journal:  Brain Res       Date:  2010-01-29       Impact factor: 3.252

Review 3.  Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2012-07-07       Impact factor: 5.996

Review 4.  The mitochondrial permeability transition in neurologic disease.

Authors:  M D Norenberg; K V Rama Rao
Journal:  Neurochem Int       Date:  2007-03-04       Impact factor: 3.921

5.  Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.

Authors:  Eric Wildon Kostuk; Jingli Cai; Lorraine Iacovitti
Journal:  Glia       Date:  2019-04-26       Impact factor: 7.452

6.  2, 2'- and 4, 4'-Cyanines are transporter-independent in vitro dopaminergic toxins with the specificity and mechanism of toxicity similar to MPP⁺.

Authors:  Chamila C Kadigamuwa; Viet Q Le; Kandatege Wimalasena
Journal:  J Neurochem       Date:  2015-08-12       Impact factor: 5.372

Review 7.  MPTP and SNpc DA neuronal vulnerability: role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview.

Authors:  V Jackson-Lewis; R J Smeyne
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 9.  Dopamine transporter mutant mice in experimental neuropharmacology.

Authors:  Raul R Gainetdinov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-05       Impact factor: 3.000

Review 10.  Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.

Authors:  Teresa R Kee; Pamela Espinoza Gonzalez; Jessica L Wehinger; Mohammed Zaheen Bukhari; Aizara Ermekbaeva; Apoorva Sista; Peter Kotsiviras; Tian Liu; David E Kang; Jung-A A Woo
Journal:  Front Aging Neurosci       Date:  2021-04-22       Impact factor: 5.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.